Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.97 USD | +0.34% | -0.17% | -12.59% |
05-16 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
05-02 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.59% | 260M | |
+12.50% | 229B | |
+14.52% | 195B | |
+17.51% | 142B | |
+28.96% | 109B | |
+3.27% | 64.85B | |
+18.16% | 54.33B | |
+7.63% | 52.09B | |
+10.95% | 45.15B | |
+5.10% | 37.39B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- Transcript : AxoGen, Inc., Q4 2022 Earnings Call, Mar 14, 2023